Article ID Journal Published Year Pages File Type
2139896 Leukemia Research 2008 4 Pages PDF
Abstract
The combination of arsenic trioxide, retinoic acid and thalidomide could have therapeutic benefit in higher risk MDS with safety.
Keywords
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Preview
Arsenic trioxide, thalidomide and retinoid acid combination therapy in higher risk myelodysplastic syndrome patients
Authors
, , , , , ,